|Company name||Medtronic, Inc.|
|Live stock price||[stckqut]MDT[/stckqut]|
|P/E compared to competitors||Good|
|Confident Investor Rating||Fair|
|Target stock price (TWCA growth scenario)||$42.43|
|Target stock price (averages with growth)||$54.48|
|Target stock price (averages with no growth)||$52.06|
|Target stock price (manual assumptions)||$41.21|
The following company description is from Google Finance: http://www.google.com/finance?q=mdt
Medtronic, Inc. (Medtronic) is a medical technology company. The Company is engaged in research, design, manufacture and sale of products to alleviate pain, restore health and extend life. It manufactures and sells device-based medical therapies. It operates in two segments: Cardiac and Vascular Group which includes, Cardiac Rhythm Disease Management, CardioVascular, Physio-Control, and Restorative Therapies Group which include Spinal, Neuromodulation, Diabetes, Surgical Technologies. Its primary customers include hospitals, clinics, third party healthcare providers, distributors and other institutions, including governmental healthcare programs and group purchasing organizations. On February 25, 2011, the Company acquired Jolife, a privately-held company. On January 13, 2011, the Company acquired Ardian, Inc. In August 2011, the Company acquired PEAK Surgical, Inc. and Salient Surgical Technologies, Inc.
Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.